Group items tagged

Medicines and healthcare are synonymous globally. As treatments become more innovative, to address unmet clinical needs, it is important that there is innovation in the pharma value chain as well. In order that patients receive the right medicine, at the right time and the right place, there is a need for a complex value chain. The full set of activities that occur prior to a patient receiving a medicine, constitute the pharmaceutical value chain. This value would differ within markets and also between markets. https://www.acldigital.com/blogs/top-10-data-integration-and-management-challenges-pharma-value-chain

Today, the United States is the largest medical device market in the world. It is estimated that by 2023 the growth of medical device industry is expected to touch $208 Billion. Medical devices sector is an integral part of healthcare industry in the United States. The manufacturers of the medical device equipment aim at integrating accuracy with automation. According to a market research report, there is an emerging trend of application of AI in the medical devices sector, and business leaders and professionals are looking for insights on the impact of this technology. https://www.acldigital.com/blogs/ai-medical-devices-emerging-future-pharma-industry

"Werbung macht Arzneimittel wirksamer Ob Kopfschmerztablette, Schnupfenmittel oder Allergiehemmer: Spots für solche rezeptfreien Medikamente sind im Fernsehen alltäglich. Die Pharma-Unternehmen geben Milliarden aus, um solche TV-Spots zu produzieren und ihre Produkte so beim Verbraucher bekannt und nach Möglichkeit auch beliebt zu machen. Ein Team von US-Forschern hat nun untersucht, wie diese Werbung den Glauben der Konsumenten in diese Medikamente beeinflusst"

ACL Digital Life Sciences has a track record of partnering successfully with some of the leading Pharmaceuticals, Biotechs, CROs, Medical Devices and MSP companies. We offer multiple sourcing models to suit your business needs. We work with an MSP of your choice, insourcing staff augmentation, insourcing and outsourcing FSP models and Project-based deliverables. We do this to provide you with the flexibility you need - whether it's for onsite or remote resources, long term or project-specific resources, SME consultation, resources available across multiple geographic areas, resources mapping US time zones or working off-hours in local time zones, among other requirements.

In Contempt of various potential advantages offered by way of modern technologies and capacities, the biopharmaceutical organization has commonly been slow to digitize its clinical trial process. Many biopharma corporations nowadays think about digital as a set of technology, structures, and superior analytics, which may include connected devices, mobile applications, artificial intelligence (AI), and robotics. The first-moving organization is also typically focusing on the fragmented solution and piloting technologies in exclusive areas of clinical trial and development to aid the existing scenario.

Developing a sound regulatory strategy, in-depth understanding of the country or region-specific regulatory requirements for specific product categories, along with accurate interpretations, implications, and applicability of such regulations, are instrumental in achieving a global outreach for medical products. Whether the product is a medical device, diagnostics, biologics, or a pharmaceutical drug, a careful consideration of the regulatory strategy early on is crucial for securing timely clearances or approvals.